Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.70 |
| ▸ | HMGCR | P04035 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.46 |
| ▸ | LTB4R | Q15722 | 4/20 | 0.44 |
| ▸ | LTB4R2 | Q9NPC1 | 3/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | PPARD | Q03181 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 2/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1545475 | 0.88 | HTT (0.70) | HTTHMGCRLMNASMN1; SMN2KMT2A | |
| SCHEMBL21662487 | 0.87 | HTT (0.50) | HTTHMGCRSMN1; SMN2KMT2AMAPT | |
| SCHEMBL23788297 | 0.85 | HTT (0.51) | HTTLMNASMN1; SMN2KMT2AMAPT | |
| SCHEMBL23788577 | 0.84 | HTT (0.50) | HTTLMNASMN1; SMN2KMT2AMAPT | |
| SCHEMBL22714672 | 0.84 | HTT (0.50) | HTTLMNASMN1; SMN2MAPTL3MBTL1 | |
| SCHEMBL23788296 | 0.84 | LTB4R (0.60) | HTTKMT2ALTB4RLTB4R2CYP3A4 | |
| SCHEMBL23778068 | 0.84 | HTT (0.50) | HTTLMNASMN1; SMN2KMT2AMAPT | |
| SCHEMBL30398255 | 0.83 | HTT (1.00) | HTTHMGCRLMNASMN1; SMN2KMT2A | |
| SCHEMBL3661837 | 0.83 | HTT (1.00) | HTTHMGCRLMNASMN1; SMN2KMT2A | |
| SCHEMBL5926354 | 0.81 | HTT (0.54) | HTTHMGCRSMN1; SMN2KMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025008288-A1 | 9-OXO-9,10-DIHYDRO-6H-PYRANO[3,2-B:4,5-B']DIPYRIDINE-8-CARBOXYLIC ACID DERIVATIVES | CENTENARA LABS AG (CH) | 2025-01-09 | — | — | WO | disclosed |
| US-11964986-B1 | 9-oxo-9,10-dihydro-6H-pyrano[3,2-b:4,5-b′]dipyridine-8-carboxylic acid derivatives | REJUVERON TELOMERE THERAPEUTICS AG (CH) | 2024-04-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11964986-B1 | 9-oxo-9,10-dihydro-6H-pyrano[3,2-b:4,5-b′]dipyridine-8-carboxylic acid derivatives | DPP9, DPYD, QDPR | HTT 1759/4885HMGCR 650/4885LMNA 3513/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.